An open label comparative clinical trial to evaluate The efiicacy of Udumbara Phala Churna and Lodhra - Shunthi Churna in the management of Asrigdara w.s.r. Heavy Menstrual Bleeding

An open label randomised comparative clinical trial to evaluate The efiicacy of Udumbara Phala Churna and Lodhra - Shunthi Churna in the management of Asrigdara w.s.r. Abnormal Uterine Bleeding (AUB O&E) - Nil

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/064711

Enrollment

Registered

2024-03-22

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N920- Excessive and frequent menstruation with regular cycle

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Subjects having confirm diagnosis of Asrigdara w.s.r. Abnormal Uterine Bleeding (AUB O&E) Abnormal Uterine bleeding due to Ovulatory disorders and Endometrial disorders (without Pelvic Pathology) Patients of age group between 20 to 40 years who are willing to take part in the study or those who have informed written consent. (Married and Unmarried)

Exclusion criteria

Exclusion criteria: patients below the age of 20 yrs and above the age of 40 yrs All male candidates are excluded

Design outcomes

Primary

Measure	Time frame
Decrease in Amount of Blood Flow Decrease in Duration of Blood FlowTimepoint: At Baseline and 90th Day	—

Secondary

Measure	Time frame
Reduction in Pain Alteration in Hb% by 1%Timepoint: at Baseline and 90th day	—

Countries

India

Contacts

Public ContactDr Himanshi Goyal

Shri Dhanwantry Ayurvedic College and Hospital

harpreet.minni@gmail.com9417039027

Outcome results